X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

    AstraZeneca Eyes Acquisition To Develop Cell Therapies

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

New mineral improves probiotic stability

Content Team by Content Team
5th May 2021
in News
New mineral improves probiotic stability

Swiss manufacturer Omya is developing a new mineral solution for greater stability, performance and survival rates of probiotics during formulation and delivery to the gut. Together with NIZO, a leading contract research company, Omya studied the mineral’s influence on probiotic viability during production and delivery processes. The new product solution was shown to be an effective stabilizing agent during spray drying, shelf-life and in-vitro digestion of the valuable microorganisms – outperforming the organic benchmark excipient maltodextrin. These results demonstrate the mineral’s high potential for probiotic applications in the food, nutraceutical and pharmaceutical industries.

The market for probiotic supplements to support healthy gut flora is booming. However, the microorganisms within these products are extremely sensitive. If exposed to excess moisture or heat, such as during spray drying, they may be damaged and lose their beneficial qualities. Therefore, a stabilizing agent is essential. With its strong water-binding properties and significant buffering capacity, the functionalized mineral from Omya is a promising inorganic probiotic carrier.

For the research performed at NIZO’s lab, Lactobacillus Plantarum (strain WCFS1) – one of the most studied probiotics – was used as a model organism. The lactobacilli cultures were mixed with either maltodextrin or Omya’s mineral solution and spray dried to evaluate their survival rates. To assess the efficiency of the stabilizers during digestion and accelerated shelf-life experiments, the resulting powders were separately blended with skim milk powder or pressed into tablets with lactose as an excipient.

A representative in-vitro digestion model demonstrated a proof-of-principle. Omya’s mineral solution outperformed maltodextrin in both matrices – milk powder and lactose tablets – delivering up to 1000 times the amount of probiotic bacteria. In line with the digestion results, the functionalized mineral also showed significantly better stabilizing effects in the milk formulation and lactose tablets compared to maltodextrin. The findings prove that the mineral can be used as a stabilizer for probiotics and pave the way for a new expertise in probiotic production, supply chain and usage.

Stefan Lander, Vice President Consumer Goods, Group Sales & Marketing at Omya: “Public awareness of gut health and its importance for wellbeing and immune health is growing. Furthermore, interest in supporting the immune system has increased massively, particularly in light of the pandemic. More and more people want to support their intestinal flora with probiotics. Our new functionalized mineral offers lots of possibilities for innovative probiotic formulations and positionings.”

Previous Post

CPhI Discover: pharma grows through partnering

Next Post

3P and Buzzard Pharmaceuticals Enter Cancer Collaboration

Related Posts

Stringent Policy around COVID Vaccines Laid by FDA
FDA Approvals

Stringent Policy around COVID Vaccines Laid by FDA

29th May 2025
Drugmakers Asked to Strictly Follow the US Pricing Reforms
Manufacturing

Drugmakers Asked to Strictly Follow the US Pricing Reforms

28th May 2025
DHL Supply Chain
News

DHL Supply Chain comes up with New Pharma Hub in Singapore

19th April 2025
Healthcare Packaging
Asia

Amcor Healthcare Packaging Expansion in Asia Pacific

16th April 2025
Drug Development

Advanced Instruments All Set To Merge With Nova Biomedical

22nd March 2025
Drug Development

Taiho Pharmaceutical Buys Araris Biotech AG For $740 Million

21st March 2025
Next Post
BMS ristol Myers Squibb Research at ASCO Demonstrates Diverse Approaches in Treating Cancer to Improve Outcomes for Patients

3P and Buzzard Pharmaceuticals Enter Cancer Collaboration

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In